Ligand Pharmaceuticals
LGND
#2818
Rank
A$8.72 B
Marketcap
A$436.10
Share price
-2.62%
Change (1 day)
40.62%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2026 (TTM): A$91.14 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.25 Billion. In 2025 the company made an earning of A$0.24 Billion, an increase over its 2024 earnings that were of A$8.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$91.14 M-62.48%
2025 A$0.24 B2848.57%
2024 A$8.23 M-91.37%
2023 A$95.46 M-7.59%
2022 A$0.10 B4%
2021 A$99.33 M296.42%
2020 A$25.05 M-97.97%
2019 A$1.23 B275.62%
2018 A$0.32 B237.48%
2017 A$97.46 M49.05%
2016 A$65.39 M55.41%
2015 A$42.07 M36.87%
2014 A$30.74 M29.59%
2013 A$23.72 M1309.35%
2012 A$1.68 M-43.97%
2011 A$3 M-113.19%
2010 -A$22.78 Million59.86%
2009 -A$14.25 Million-61.33%
2008 -A$36.85 Million-58.75%
2007 -A$89.32 Million20.52%
2006 -A$74.12 Million81.27%
2005 -A$40.89 Million
2003 -A$28.47 Million-20.6%
2002 -A$35.85 Million4.38%
2001 -A$34.35 Million-48.83%
2000 -A$67.12 Million-19.74%
1999 -A$83.62 Million-19.06%
1998 -A$0.11 Billion126.71%
1997 -A$45.57 Million-5.83%
1996 -A$48.39 Million136.23%
1995 -A$20.49 Million-33.97%
1994 -A$31.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.78 B 30,636.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$10.34 B 11,340.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$51.60 B 56,983.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.40 B 18,045.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.28 Billion-407.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$9.97 B 10,937.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.82 B 18,504.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$10.61 B 11,646.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-A$91.85 Million-201.60%๐Ÿ‡บ๐Ÿ‡ธ USA